Dale Hollingshead

Dale Hollingshead is the current Chief Financial Officer of Object Pharma, Inc. Since November 2018. Prior to this role, Dale held the position of CFO at Valkyrie Brands, LLC from January 2018 to December 2018, where Dale was involved in consulting, investments, and acquisitions. With a background in finance and strategy, Dale has held various executive positions in financial planning, analysis, and management throughout their career, including roles at Lantern Credit, LLC, West Pacific Medical Lab, and Transcapital Investments. Dale's educational background includes an MBA in Finance & Strategy from The Wharton School and a BS in Economics from Brigham Young University.